These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26232019)

  • 1. Bioresorbable Vascular Scaffolds for Heavily Calcified Lesions: How to Tackle the Rugged Passage?
    Miyazaki T; Panoulas VF; Sato K; Latib A; Colombo A
    J Invasive Cardiol; 2015 Aug; 27(8):E167-8. PubMed ID: 26232019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery perforation and acute scaffold thrombosis after bioresorbable vascular scaffold implantation for a calcified lesion.
    Lee WC; Fang HY; Wu CJ
    Int J Cardiol; 2016 Nov; 222():620-621. PubMed ID: 27517650
    [No Abstract]   [Full Text] [Related]  

  • 3. Can bioabsorbable scaffolds be used in calcified lesions?
    Basavarajaiah S; Naganuma T; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):48-52. PubMed ID: 23592566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds.
    Caiazzo G; Longo G; Giavarini A; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; Secco GG; De Rosa S; Indolfi C; Di Mario C
    Int J Cardiol; 2016 Oct; 221():352-8. PubMed ID: 27404705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography findings after longitudinal ablation for an underexpanded stent in a heavily calcified lesion: a case report.
    Koide M; Inoue K; Matsuo A; Fujita H
    BMC Cardiovasc Disord; 2016 Nov; 16(1):241. PubMed ID: 27894264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries.
    Lane JP; Perkins LE; Sheehy AJ; Pacheco EJ; Frie MP; Lambert BJ; Rapoza RJ; Virmani R
    JACC Cardiovasc Interv; 2014 Jun; 7(6):688-95. PubMed ID: 24835327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a scoring balloon for optimal lesion preparation prior to bioresorbable scaffold implantation: a comparison with conventional balloon predilatation.
    Miyazaki T; Latib A; Ruparelia N; Kawamoto H; Sato K; Figini F; Colombo A
    EuroIntervention; 2016 Apr; 11(14):e1580-8. PubMed ID: 27056118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
    Rizik DG; Shah MG; Burke RF
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):899-901. PubMed ID: 27545489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in Real World and Complex Coronary Disease: Procedural and 30-day Outcomes at Two Australian Centres.
    Robaei D; Back LM; Ooi SY; Pitney MR; Jepson N
    Heart Lung Circ; 2015 Sep; 24(9):854-9. PubMed ID: 25778622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment.
    Sorrentino S; De Rosa S; Ambrosio G; Mongiardo A; Spaccarotella C; Polimeni A; Sabatino J; Torella D; Caiazzo G; Indolfi C
    BMC Cardiovasc Disord; 2015 Dec; 15():169. PubMed ID: 26654975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Acute Recoil Following Bioresorbable Scaffold Implantation in Fibrocalcific Lesion Detected by Optical Frequency-Domain Imaging.
    Kawamoto H; Ruparelia N; Tanaka A; Latib A; Colombo A
    J Invasive Cardiol; 2016 Mar; 28(3):E34-6. PubMed ID: 26945257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 'Guideliner' catheter to overcome failure of delivery of Absorb™ Bioresorbable Vascular Scaffold in calcified tortuous coronary lesions: technical considerations in 'Real World Patients'.
    Seth A; Ravisekar V; Kaul U
    Indian Heart J; 2014; 66(4):453-8. PubMed ID: 25173205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging.
    Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A
    Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.
    Karanasos A; Van Mieghem N; van Ditzhuijzen N; Felix C; Daemen J; Autar A; Onuma Y; Kurata M; Diletti R; Valgimigli M; Kauer F; van Beusekom H; de Jaegere P; Zijlstra F; van Geuns RJ; Regar E
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term implications of a bioresorbable vascular scaffold implantation on the local endothelial shear stress patterns.
    Bourantas CV; Papafaklis MI; Garcia-Garcia HM; Farooq V; Diletti R; Muramatsu T; Zhang Y; Kalatzis FG; Naka KK; Fotiadis DI; Onuma Y; Michalis LK; Serruys PW
    JACC Cardiovasc Interv; 2014 Jan; 7(1):100-1. PubMed ID: 24456718
    [No Abstract]   [Full Text] [Related]  

  • 16. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
    Pichette M; Chevalier F; Généreux P
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioresorbable vascular scaffold collapse causes subacute thrombosis.
    Ruiz-Salmerón RJ; Pereira S; de Araujo D
    J Invasive Cardiol; 2014 Jul; 26(7):E98-9. PubMed ID: 24993999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.
    Gomez-Lara J; Brugaletta S; Farooq V; van Geuns RJ; De Bruyne B; Windecker S; McClean D; Thuesen L; Dudek D; Koolen J; Whitbourn R; Smits PC; Chevalier B; Morel MA; Dorange C; Veldhof S; Rapoza R; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2011 Jul; 4(7):789-99. PubMed ID: 21777888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.